Bariatric Surgery Versus Intensive Medical Therapy For Diabetes — 5-Year Outcomes

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

Long-term results from randomized, controlled trials that compare medical therapy with surgical therapy in patients with type 2 diabetes are limited.
We assessed outcomes 5 years after 150 patients who had type 2 diabetes and a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of 27 to 43 were randomly assigned to receive intensive medical therapy alone or intensive medical therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy. The primary outcome was a glycated hemoglobin level of 6.0% or less with or without the use of diabetes medications.
Of the 150 patients who underwent randomization, 1 patient died during the 5-year follow-up period; 134 of the remaining 149 patients (90%) completed 5 years of follow-up. At baseline, the mean (±SD) age of the 134 patients was 49±8 years, 66% were women, the mean glycated hemoglobin level was 9.2±1.5%, and the mean BMI was 37±3.5. At 5 years, the criterion for the primary end point was met by 2 of 38 patients (5%) who received medical therapy alone, as compared with 14 of 49 patients (29%) who underwent gastric bypass (unadjusted P=0.01, adjusted P=0.03, P=0.08 in the intention-to-treat analysis) and 11 of 47 patients (23%) who underwent sleeve gastrectomy (unadjusted P=0.03, adjusted P=0.07, P=0.17 in the intention-to-treat analysis). Patients who underwent surgical procedures had a greater mean percentage reduction from baseline in glycated hemoglobin level than did patients who received medical therapy alone (2.1% vs. 0.3%, P=0.003). At 5 years, changes from baseline observed in Continue reading

Rate this article
Total 1 ratings
Psoriasis severity may influence type 2 diabetes risk

Psoriasis severity may influence type 2 diabetes risk

People living with psoriasis are not only at higher risk of type 2 diabetes, but their risk also rises in line with the skin disease's severity, according to recent research from the University of Pennsylvania Perelman School of Medicine in Philadelphia.
The team — led by Joel M. Gelfand, a professor of dermatology and epidemiology — reports the findings in a paper that was published recently in the Journal of the American Academy of Dermatology.
"We know psoriasis is linked to higher rates of diabetes," Prof. Gelfand explains, "but this is the first study to specifically examine how the severity of the disease affects a patient's risk."
He and his team suggest that the findings support the idea that there is a biological connection between psoriasis and type 2 diabetes.
Psoriasis and diabetes
Psoriasis is a serious medical condition that affects around 7.5 million people in the United States. It develops from a fault in the immune system that disrupts the normal biology of the skin and joints.
About 80–90 percent of people with psoriasis have plaque psoriasis, an inflammatory condition in which the immune system sends faulty signals that make skin cells grow too fast.
As the cells reach the surface of the skin and die, they form lesions that appear as thick red patches covered with silvery scales. The patches typically develop on the elbows, palms, face, scalp, lower back, knees, and soles of the feet, but they can also affect the mouth, nails, genitals, and other places.
Around 40 percent of people with psoriasis have psoriatic arthritis, which is a form of the dise Continue reading

Why Aren’t There More People of Color at Diabetes Conferences?

Why Aren’t There More People of Color at Diabetes Conferences?

I grew up in a small town in Northeast Georgia with a fairly large African American population, but a lot of the things I was interested in wasn’t popular with most of the black kids in my community. As a kid, I was usually the only black kid into something, whether it was band, 4H, or chorus.
I was diagnosed with Type 1 diabetes around 1989 when I was 25 years old. I had all the typical symptoms but didn’t think much of it, since I knew nothing about diabetes. Eventually, my roommate set me up with an appointment with the urologist (you read that right) who diagnosed me.
Back in my day, there was no Meetup or Myspace, and definitely no Facebook, so meeting others who lived with diabetes was pretty much a crapshoot. When I found a group, it turned out to be made up mostly of seniors; as a 25-year-old guy, that was not my idea of a party.
It would be many years before I found groups and organizations that helped people with diabetes connect and support each other. I basically had to wait until I had internet access to find these groups.
By the time I transitioned all my friends from Myspace to Facebook, I had my first insulin pump. I also had my first experience with diabetic retinopathy in one eye. By the time my other eye became damaged, I had begun taking my diabetes more seriously than I had in years past. I tried to learn more about how I could save my vision and my overall health.
Facebook helped me connect with several advocates, and others with diabetes. Through those connections I was able to learn more about the effects of diabetes, not just on Continue reading

The incredible colour changing tattoos that monitor the blood sugar levels of people with diabetes in real-time

The incredible colour changing tattoos that monitor the blood sugar levels of people with diabetes in real-time

Researchers have developed a biosensing tattoo ink that reacts to sugar in the blood to help diabetics control their conditions.
The colour-changing ink turns the body's surface into an 'interactive display' to alert diabetics when their blood sugar is too low or high.
When blood sugar goes up, the glucose sensing ink changes from blue to brown in real-time, a colour change that reverses when blood sugar drops.
Scroll down for video
‹ Slide me ›
The ink senses changes to the body's interstitial fluid - the liquid that surrounds tissue cells in the body.
If blood sugar is low, it changes from brown to blue, and if high, it changes from blue to brown.
The tattoos could one day act as a non-invasive method for diabetics to control their condition.
The ink acts as a biosensor that reads interstitial fluids - the liquids that surround tissue cells in the body.
Other biosensing tattoo inks developed by the team, from the Massachusetts Institute of Technology, monitor the body's salt and pH levels.
The salt sensing inks, which track the mineral by measuring sodium levels, fluoresce under UV light, shifting to an intense green when high salt levels are detected.
The pH sensing inks respond to alkalinity and change from pink to purple as it increases.
The researchers suggest that their tattoo inks, which they say are currently just at the 'proof of concept' stage, could offer new ways of monitoring the body.
For diabetics, the glucose sensing ink provides a way to track blood sugar levels without having to prick the skin and take a blood sample every few hours.
One biosensing ta Continue reading

Color-changing tattoos could revolutionize how we treat diabetes (VIDEO)

Color-changing tattoos could revolutionize how we treat diabetes (VIDEO)

Get short URL
Scientists are testing new tattoo ink which morphs in color depending on changes to your health.
The Dermal Abyss project by researchers at Massachusetts Institute of Technology (MIT) is being tipped to change the way common ailments like diabetes are monitored.
READ MORE: Almost 1/3 of people worldwide overweight, says new study
Using biosensor ‘ink’, which interacts with glucose, sodium and other chemical compounds produced by humans, it’s hoped the tattoos may be able to show when a person’s body is experiencing health-impacting changes.
For example, Dermal Abyss may make the daily piercing of the skin a thing of the past for diabetics, since glucose levels would be revealed through the colors of a tattoo.
It could also provide an instant warning to those in danger of suffering from potentially fatal complications deriving from hyperglycemia.
Developed by MIT researchers Katia Vega, Xin Liu, Viirj Kan and Nick Barry, the first stage of tattoo testing was carried out using skin from a dead pig.
READ MORE: Artist develops ‘soundwave’ tattoos to immortalize voices of nearest & dearest
Footage of the technology explains how traditional inks are replaced by biosensors “whose colors change in response to variations in the interstitial fluid.”
According to MIT, the exploratory stage of the project is still ongoing and there are no plans to pursue clinical trials at this moment. Continue reading

No more pages to load

Popular Articles

  • World Diabetes Day - Research uncovering link between gut health and pregnancy outcomes

    As part of World Diabetes Day, an Australian Diabetes Society’s (ADS) research grant recipient discusses her work in diabetes and pregnancy and shares tips for women and healthcare professionals on optimising wellness for mums and babies. World Diabetes Day, November 14, 2017, aims to raise awareness of the right of all women with diabetes to a healthy future. In Australia there are currently: 6 ...

  • Diabetes Patients Seeing Better Outcomes Through Technology

    Tuesday, June 06, 2017 |by Paul Wynn, special to AAMCNews Diabetes Patients Seeing Better Outcomes Through Technology When David Klonoff, MD, started practicing endocrinology more than 35 years ago, urine tests were the standard for diabetes screenings. We had to mix chemicals with the urine to get a resultand it wasnt very accurate, said Klonoff, a clinical professor at the University of Cali ...

  • Drunk versus diabetes: How can you tell?

    Dispatch calls your EMS unit to the side of a roadway, where police officers have detained a driver on suspicion of driving under the influence of alcohol intoxication. You find the female driver handcuffed in the back seat of a police cruiser. She is screaming profanities and hitting her head against the side window. An officer tells you that she was weaving in and out of traffic at highway speed ...

  • Continuous Versus Flash Glucose Monitoring To Reduce Hypoglycemia In Type 1 Diabetes

    Continuous glucose monitoring may reduce hypoglycemia fear. The Dexcom G5 system was approved by the FDA in 2016 and was later permitted for use to replace finger-stick testing to determine insulin dose. The REPLACE-BG study proved its safety and effectiveness in adults with well-controlled type 1 diabetes at low risk for severe hypoglycemia. The FreeStyle Libre Pro System was also approved last y ...

  • The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus

    The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus Westman et al; licensee BioMed Central Ltd.2008 Dietary carbohydrate is the major determinant of postprandial glucose levels, and several clinical studies have shown that low-carbohydrate diets improve glycemic control. In this study, we tested the hypothesis that ...

  • Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

    Metformin is widely used to treat gestational diabetes (GDM), but many women remain hyperglycaemic and require additional therapy. We aimed to determine recruitment rate and participant throughput in a randomised trial of glibenclamide compared with standard therapy insulin (added to maximum tolerated metformin) for treatment of GDM. We conducted an open label feasibility study in 5 UK antenata ...

  • U-40 Versus U-100 Insulin Syringes and Pens

    I recently got a letter asking me to help choose the best insulin syringe for a pet. So today I’ll first explain the goofy lingo we use to describe insulin syringes and then discuss needles and pens and syringe volume. It’s really quite simple once you break it down. Some of it is critical to proper dosing and some of it is merely personal preference. What is the Difference Between U-40 and U- ...

  • Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations

    Type 2 diabetes mellitus (DM) and obesity are chronic diseases that often coexist. Combined, they account for tremendous morbidity and mortality. Approximately 85% of all patients with type 2 DM have a body mass index (BMI) categorizing them as overweight (BMI 25.0–29.9 kg/m) or obese (BMI > 30.0 kg/m) (Figure 1). Obesity is strongly associated with diabetes and is a major cause of insulin resis ...

  • Do You Have Diabetes? 5 Tips for Successful Heart Surgery

    While having diabetes puts you at a greater risk for complications during surgery, you can put a cap on these risks by being sure your diabetes is well controlled. Even small changes in blood glucose levels make a big difference. If blood sugar is not well-managed, it raises risks for wound infections, which account for about two-thirds of post-operative problems with diabetes. High blood sugar al ...

Related Articles